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Poliovirus (PV) causes a drastic inhibition of cellular cap-dependant protein synthesis due to the cleavage of translation factors eukaryotic
initiation factor 4G (eIF4G) and poly(A) binding protein (PABP). Only about half of cellular PABP is cleaved by viral 2A and 3C proteinases
during infection. We have investigated PABP cleavage determinants that regulate this partial cleavage. PABP cleavage kinetics analyses indicate
that PABP exists in multiple conformations, some of which are resistant to 3Cpro or 2Apro cleavage and can be modulated by reducing potential.
Cleavage reactions containing a panel of PABP-binding proteins revealed that eukaryotic release factor 3 (eRF3) and PABP-interacting protein 2
(Paip2) modulate and interfere with the cleavage susceptibility of PABP, whereas all other PABP-binding proteins tested do not. We show that
PABP on cellular polysomes is cleaved only by 3Cpro and that Paip2 does not sediment with polysomes. Also, viral polysomes contained only full-
length PABP, however, cellular or viral ribosomes were equally susceptible to 3Cpro cleavage in vitro. Finally, we determined that precursor 3CD
and mature 3Cpro have equivalent cleavage activity on purified PABP, but only 3Cpro cleavage activity was stimulated by PABP-binding viral
RNA. The results further elucidate complex mechanisms where multiple inherent PABP conformations and protein and RNA interactions both
serve to differentially regulate PABP cleavage by 3CD, 3Cpro and 2Apro.
© 2008 Elsevier Inc. All rights reserved.Keywords: Poly(A)-binding protein; PABP; Poliovirus; Paip2; eRF3; ProteinaseIntroduction
Poliovirus (PV) is the prototypic member of the Picorna-
viridae family. It contains a 7.5 kb positive single stranded
RNA genome and translation of the poliovirus genome during
viral infection generates two mature viral proteinases, 2A and
3C proteinases (2Apro and 3Cpro), and a proteinase-active
polypeptide precursor (3CD). These viral proteinases target a
wide variety of proteins in the infected cell with many of these
targets being cleaved to completion. During poliovirus
infection multiple cellular processes are disrupted; most
notably inhibition of cap-dependent host protein synthesis
through the cleavage of eukaryotic initiation factor 4G I and II⁎ Corresponding author. Department of Molecular Virology and Microbiol-
ogy, Room 860E, Baylor College of Medicine, One Baylor Plaza, Houston, TX
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doi:10.1016/j.virol.2008.02.002(eIF4G-I and -II) by 2Apro and poly(A)-binding protein
(PABP) by 2Apro and 3Cpro (Etchison et al., 1982; Joachims
et al., 1999; Kuyumcu-Martinez et al., 2002; Kuyumcu-
Martinez et al., 2004b; Lamphear et al., 1993). PABP and
eIF4G both possess RNA-binding capabilities and act as
scaffold proteins, supporting protein–protein interactions with
multiple translation factors. While eIF4G is rapidly and
completely cleaved by cellular- and poliovirus 2A proteinases
(Bovee et al., 1998; Krausslich et al., 1987; Zamora et al.,
2002), only about half of the total PABP in the cell is by
cleaved late infection, though this is preferentially PABP
associated with the translational machinery (Kuyumcu-Marti-
nez et al., 2002). The molecular determinants that regulated
PABP cleavage are unknown.
PABP is a highly abundant cytoplasmic protein, ~4 µM in
HeLa cells, suggesting a three-fold excess of PABP protein
over potential mRNA-binding sites (Gorlach et al., 1994). Be-
sides now being recognized as a translation initiation factor
(Kahvejian et al., 2005), PABP has also been implicated in
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2000; Gorlach et al., 1994; Wormington et al., 1996). PABP
is broadly comprised of two functional domains, an N-ter-
minal domain with four RNA recognition motifs (RRMs) and
a C-terminal domain (PABP-CTD) containing a proline-rich
linker region tied to a globular protein-binding domain (PABC).
The four RRMs at the N-terminus each display different RNA-
binding affinities and specificities. RRM1 and RRM2 play a
pivotal role in poly(A) binding, while RRM3 and RRM4
have relatively higher binding affinity to A-rich sequences
interspersed with other nucleotides (Deo et al., 1999; Khanam
et al., 2006; Sladic et al., 2004). The PABP-CTD contains an
undefined homo-oligomerization domain and the ~70 amino
acid conserved C-terminal PABC motif bears binding motifs
for multiple proteins.
PABP associates with a wide variety of proteins. Several viral
proteins, including turnip mosaic virus Vpg-Pro polypeptide
(Leonard et al., 2004), herpes simplex virus ICP27 (Fontaine-
Rodriguez et al., 2004), Kaposi's sarcoma-associated herpes-Fig. 1. Biphasic 3C cleavage kinetics on PABP. A. Schematic of PABP, depicting the
(gray arrows) and some of the mapped recognition sites for the different RNA and pr
Purified His-PABP or HeLa S10 cell lysates were used as substrate for cleavage with 3
Recombinant His-G3BP or S10 lysates were treated with proteinase as in panel B. D. G
immunoblots. E. PABP in vitro cleavage with 2Apro (0.5 µg) incubated with HeLa S10
PABP or eIF4GI in HeLa lysates by 2Apro, determined from densitometric analysis
followed by immunoblot analysis with antibodies against the indicated proteins. Aste
cleavage generates a 52 kDa fragment (White et al., 2007), while cleavage of eIF4Gvirus K10/10.1 protein (Kanno et al., 2006) and poliovirus 3CD
polypeptide (Herold and Andino, 2001) interact with PABP to
possibly regulate viral or cellular processes. Among cellular
proteins, BRCA1, eIF4G and upstream of N-Ras (unr) associate
with different regions within the N-terminus of PABP (Chang
et al., 2004; Dizin et al., 2006; Imataka et al., 1998). Two
different PABP Associating Motifs, termed PAM1 and PAM2
(Roy et al., 2002), have been identified in a wide array of
eukaryotic proteins (Albrecht and Lengauer, 2004), mediating
their interaction with the PABC domain. Proteins containing
PAMmotifs include eIF4B, eukaryotic Release Factor 3 (eRF3),
Poly r(C) Binding Protein 2 (PCBP2), Apc5, Transducer of
erbB2 (Tob) and ataxin-2 (Herold and Andino, 2001; Hoshino
et al., 1999; Koloteva-Levine et al., 2004; Le et al., 1997; Okochi
et al., 2005; Satterfield and Pallanck, 2006). Additionally, PABP
has two binding motifs for the PABP-interacting proteins 1 and 2
(Paip1/2), one near the N-terminus and one within the PABC
(Craig et al., 1998; Khaleghpour et al., 2001a,b; Roy et al.,
2002). With the extensive list of known and predicted PABP-location of RRMs, the primary sites for cleavage of the enteroviral proteinases
otein–protein interactions (black arrows). B. PABP in vitro cleavage with 3Cpro.
C proteinase (1 µg) for 0, 10, 30 or 60 min. C. G3BP in vitro cleavage with 3Cpro.
raph of cleavage of PABP and G3BP determined from densitometric analysis of
lysate. F. Cleavage of eIF4GI in HeLa lysates by 2Apro. G. Graph of cleavage of
of immunoblots. The reactions in B, C, E and F were resolved by SDS-PAGE
risks indicate PABP or G3BP degradation products produced in bacteria. G3BP1
I isoforms generates multiple cleavage products (2Acps).
Fig. 2. Differential activation of PABP cleavage by reducing potential.
Recombinant His-PABP (500 ng) was incubated with 2Apro (0.5 µg) or 3Cpro
(1 µg) for various times in buffer containing the indicated concentrations of DTT.
PABP and cleavage products were analyzed by immunoblot and full-length (FL)
and cleavage products are indicated on the right. Migration of molecular weight
standards is shown on the left. Percent PABP cleavage determined by
densitometric analysis is shown below each lane.
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expected that many of these interactions are highly dynamic and
dependent on the state of the cell and that PABP pools participate
in several distinct types of protein/RNA complexes at any time.
The PABP-CTD is targeted for proteolytic cleavage by en-
teroviral proteinases, and contains one cleavage site for 2A
proteinase and two main cleavage sites for 3C proteinase,
all within the proline-rich linker domain. A third poliovirus
proteinase, 3CD, the precursor for the mature form of 3C
proteinase, shares substantial substrate specificity with 3C
proteinase, yet, it is unknown if 3CD can also target PABP for
cleavage. While it has been shown that polioviral proteinases
preferentially target PABP molecules associated with crude cell
fractions containing translation components and PABP bound to
poly(A) RNA (Kuyumcu-Martinez et al., 2002), it is unclear
why the majority of PABP in cells is not cleaved. Moreover, the
molecular mechanisms and determinants that regulate PABP
substrate recognition by the viral proteinases are unknown.
Since most PABP–protein interactions involve the PABP-CTD,
it is of interest to determine if these interactions modulate
the susceptibility of PABP to viral proteinases. Further, it is
unknown if viral proteinases differentially target PABP bound
to cellular versus viral mRNA. Here we show kinetics analy-
ses of PABP cleavage reactions that suggest PABP exists in
multiple conformations, one of which is resistant to 3Cpro or
2Apro. We determined that Paip2 and eRF3 negatively modulate
the viral proteinase susceptibility of PABP when using different
sources of PABP and that Paip2 strongly inhibits 2Apro cleavage
of non-ribosome associated PABP pools, while it only partly
inhibited 3Cpro cleavage on PABP associated with ribosomes.
PABP pools associated with viral and cellular polysomes
were equally susceptible to 3Cpro cleavage, yet active viral
polysomes contained only intact PABP. Additionally, we show
that 3Cpro and 3CD have equivalent proteolytic activity versus
several PABP substrates. These results further define the PABP
complexes targeted for proteolytic cleavage during infection.
Results
Biphasic PABP cleavage kinetics by 3C
Fig. 1A depicts a schematic of PABP showing protein motifs
and known viral proteinase cleavage sites. PABP interacts with
a varied array of cellular and viral proteins and some of the
mapped interaction domains on PABP are shown. Since it has
been established that viral infection does not result in complete
PABP cleavage, we sought to investigate mechanisms that
may limit or regulate PABP cleavage. Fig. 1B shows kinetics
analysis of cleavage of purified recombinant PABP with 3Cpro
and reveals a typical biphasic pattern where about 30% of total
PABP was rapidly cleaved in 10 min, followed by a much
slower cleavage rate that did not reach completion by 60 min or
extended incubation periods (data not shown). The slower
cleavage rate was not significantly enhanced by addition of
fresh proteinase after the first hour of incubation (data not
shown). 3Cpro cleavage of endogenous PABP in HeLa S10
lysates also displayed a rapid initial cleavage rate where 70%cleavage required only 10 min incubation but very little addi-
tional substrate was cleaved upon extended incubation periods.
In contrast, the Ras-GTPase activating protein SH3 domain-
Binding Protein 1 (G3BP1), a novel substrate targeted for
proteolytic cleavage by 3C proteinase (White et al., 2007), was
rapidly cleaved to completion when supplied as purified re-
combinant protein or as endogenous protein in HeLa S10
lysates (Fig. 1C), indicating that the 3Cpro was highly active.
Therefore, the lack of complete cleavage of purified recombi-
nant PABP by this proteinase suggests PABP exists in multiple
conformations, some of which are not proteinase-susceptible
and that PABP does not exchange conformations rapidly. In
addition, as previously reported, cleavage of purified recom-
binant PABP with 3C proteinase heavily favored the 3Cpro
primary cleavage site (Q537/G538) over the 3C
Alt cleavage site
(Q413/T414); very little or no cleavage product resulting from
the latter was observed in most reactions (data not shown). In
contrast, in vitro cleavage of PABP within HeLa S10 cell lysates
or during poliovirus infection in vivo consistently resulted in
significant cleavage at both the primary 3C and 3CAlt cleavage
sites (Fig. 1B) (Kuyumcu-Martinez et al., 2002). This suggests
that recombinant and endogenous PABP may exist in different
conformations, some inherently resistant to cleavage, or that
different protein–protein interactions within the S10 lysate
may modulate cleavage or expose different cleavage sites.
Similar cleavage assays with 2Apro and PABP revealed that
PABP in a HeLa S10 lysate is also highly resistant to cleavage
by this proteinase despite high 2Apro activity versus eIF4GI
(Fig. 1E,F). In this case the initial cleavage rate was very slow
and remained constant for 60 min before slowing down further
upon extended incubation (Fig. 1G). Extended incubation also
revealed a biphasic cleavage profile. Incubation of 2Apro with
recombinant His-PABP under typical assay conditions resulted
in relatively poor and variable cleavage ranging from 0–20%
(Fig. 2, lanes 1–4). This suggested that most purified His-PABP
usually exists in a conformation not suitable for 2Apro recog-
nition and binding.
A recent report suggested PABP exists in several configura-
tions via multimerization or formation of a looped structure
stabilized by disulfide bridging (Yao et al., 2007). Our assay
Fig. 3. PABP-binding proteins modulate cleavage by viral proteinases. A. Recombinant His-PABP (500 ng) was incubated with buffer control (His-PABP) or with
3Cpro (1 µg) or 2Apro (0.5 µg). Test cleavage reactions contained 500 ng of recombinant GST-Paip2, GST-Paip1, His-eRF3, GST-ΔeIF4GI, MBP-unr, His-PCBP2 or
His-eIF4B as indicated plus 3 mM DTT. Cleavage of PABP was performed for 1 h at 37 °C, followed by immunoblot analysis with PABP antibody. The migration of
the molecular weight markers is shown on the left, and on the right, the location of full-length PABP (FL) and its cleavage products (cp) for the 2A- and 3C-proteinases.
B and C. Percent cleavage by 3Cpro or 2Apro, respectively, determined by densitometric analysis from 2–3 separate experiments. Values depict the mean and standard
error of the mean.
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however we tested the effect of increased DTT on cleavage
reactions using His-PABP. These results indicated that partial
cleavage of PABP by 3Cpro cannot be significantly altered by
additional DTT (Fig. 2). In contrast, higher reducing potential in
the buffer did activate partial cleavage by 2Apro but had no
effect on 2Apro-mediated cleavage of eIF4G (data not shown).
Thus, substrate conformational changes imposed by higher
DTT differentially affected only one protease–PABP interac-
tion. Taken together, the results suggest PABP exists in various
molecular conformations that exhibit differing inherent clea-
vage sensitivity by viral proteinases.
Paip2 and eRF3 modulate the cleavage susceptibility of
recombinant PABP by viral proteinases
Since PABP interacts with a large number of cellular proteins
we wished to determine if protein–protein interactions alter the
susceptibility of PABP to viral proteinases. Fig. 3 shows in vitro
cleavage assays using a panel of paired recombinant proteins.
Similar to Figs. 1 and 2, addition of 3Cpro resulted in cleavage
of only about 40% of PABP in repeat assays. Likewise, addition
of 2Apro under suitable buffer conditions to measure cleavage
also resulted in only about 18% PABP cleavage, reinforcing the
existence of proteinase-resistant PABP conformations within
the population. When several PABP-binding proteins were
added to these reactions they had no significant effect on
proteinase cleavage catalyzed by either 2Apro or 3Cpro. Theseproteins included GST-Paip1, a GST-fused fragment of the
eukaryotic initiation factor 4G-I (eIF4GI) containing the
binding motif for PABP (amino acids 41–220) (GST-ΔeIF4GI),
maltose-binding protein-unr fusion (MBP-unr), His-PCBP2 or
His-tagged eIF4B. The cleavage of PABP by viral proteinases
also remained unaffected when GST alone or a GST-fused
truncated form of Tob1 (GST-Tob 1–170) was added to the
cleavage reaction (data not shown). In contrast, GST-Paip2
partly inhibited the cleavage of recombinant His-PABP with
3Cpro or 2Apro proteinases (Fig. 3). Similarly, addition of His-
eRF3 led to significant inhibition of PABP cleavage with 2A
and 3C proteinases (Fig. 3B,C).
Dose dependence of PABP cleavage inhibition by Paip2 and
eRF3
To investigate the stoichiometry of the modulation of PABP
cleavage by Paip2 and eRF3, we conducted cleavage assays
examining dose responses of proteinase and proteins in these
assays. Fig. 4A depicts a cleavage assay utilizing His-PABP as
a substrate for cleavage by 3C (lanes 1–8) or 2A proteinases
(lanes 9–16). Addition of increasing concentrations of Paip1
(lanes 2–4 and 10–12) did not affect 3Cpro- or 2Apro-mediated
cleavage of PABP (lanes 1 and 9, respectively). At the high-
est concentration of Paip1 tested, increasing concentrations
of proteinases led to a dose-dependent increase in cleavage
of PABP by 3Cpro and 2Apro proteinases (lanes 6–8 and 14–
16, respectively). The same assay was conducted utilizing
Fig. 4. Paip2 and eRF3 inhibit cleavage of recombinant His-PABP in a dose-dependent manner. Recombinant His-PABP (~500 ng) was subjected to cleavage by viral
proteinases in the presence or absence of increasing concentrations of GST-Paip1 (panel A) or GST-Paip2 (panel B). His-PABP was cleaved with 3Cpro (3 µg) in the
absence (lane 1) or presence of increasing concentrations of recombinant GST-Paip proteins (1, 2 or 3 µg (3–9-fold molar excess of Paip1 or Paip2 over PABP),
lanes 2–4). Alternatively, His-PABP was incubated with GST-Paip (1 or 2) (3 µg) alone (lane 5) or with increasing concentrations of 3Cpro (1, 2 or 3 µg, lanes 6–8).
His-PABP was also cleaved with 1.5 µg of 2A proteinase alone (lanes 9) or in the presence of increasing concentrations of GST-Paip (1 or 2) proteins (1, 2 or 3 µg,
lanes 10–12) or incubated with the GST-Paip alone (lane 13) or with increasing concentrations of 2Apro (0.5, 1 or 1.5 µg of 2A, lanes 14–16). C. Recombinant His-
PABP (1 µg) was incubated alone (lane 1) or with 1 µg of 3Cpro or 0.5 µg of 2Apro in the absence (lanes 2 and 7, respectively) or presence of increasing concentrations
of His-eRF3 (1 or 2 µg, 1–2-fold molar excess of eRF3 over PABP, lanes 3–4 and 8–9) or His-PCBP2 (1 or 2 µg, 2–4-fold molar excess of PCBP2 over PABP, lanes
5–6 and 10–11). All cleavage reactions contained 3 mMDTTand were analyzed by immunoblot with an anti-PABP polyclonal antibody. Percent cleavage in all panels
was determined by densitometry. The migration of the molecular weight markers is shown on the left, and on the right, the location of full-length PABP (FL) and its
cleavage products (cp) for the 2A- and 3C-proteinases. The asterisk represents a crossreactive protein in the His-eRF3 preparation.
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increasing concentrations of Paip2 inhibited cleavage of PABP by
3Cpro (lanes 2–4) in a dose-dependent manner. The inhibitory
effect exerted by Paip2 was more pronounced on 2Apro, as the
lesser concentrations of Paip2 that led to partial inhibition of
PABP cleavage by 3Cpro resulted in complete inhibition of 2Apro-
directed cleavage of PABP (compare lanes 2–4 and 10–12). Paip2
inhibited proteolytic cleavage of PABP by 3Cpro at low proteinase
concentrations, but the inhibition was abrogated with higher
concentrations of 3Cpro (lanes 6–8). On the other hand, higher
concentrations of 2Apro did not overcome Paip2 inhibition.
We also examined if eRF3 inhibition of PABP cleavage by
viral proteinases was dose-dependent (Fig. 4C). Increasing
concentrations of recombinant His-tagged eRF3 led to partial
inhibition of 3Cpro- and 2Apro-proteolytic cleavage of PABP
that increased modestly (lanes 2–4 and 7–9). This inhibitory
effect was not seen when similar amounts of His-tagged PCBP2
were added in the same assay as a negative control.Paip2 and eRF3 inhibit cleavage of PABP in cell lysates
We were interested in determining if the observed inhibition
of PABP cleavage by Paip2 and eRF3 occurred with native
PABP in the context of a HeLa cell lysate. As shown previously,
addition of 3Cpro cleaved only 60–70% of the PABP in the
lysate (Fig. 5A). However, addition of either GST-Paip2 or His-
eRF3 inhibited cleavage of endogenous PABP by 3Cpro by
about 3-fold (Fig. 5A). When 2Apro was incubated with lysate, a
smaller portion of PABP was cleaved and addition of Paip2 and
eRF3 significantly inhibited this cleavage.
In order to show that recombinant Paip2 or eRF3 did not
inhibit 3Cpro or 2Apro activity per se, we conducted in vitro
cleavage assays of endogenous G3BP1 or eIF4GI in HeLa S10
lysates. G3BP1 and eIF4G were efficiently cleaved by 3C- and
2A-proteinases, respectively (Fig. 5B) and the cleavage was not
significantly affected by the addition of GST-Paip2 or His-
eRF3. When other PABP-binding proteins were tested in similar
Fig. 5. Paip2 and eRF3 inhibit cleavage of PABP in cell lysates. A. HeLa S10
lysate (200 µg) was incubated with buffer control or subjected to cleavage with
3Cpro (1 µg) or 2Apro (0.5 µg) in the presence or absence of eRF3 (500 ng) or
Paip2 (500 ng). B. Control cleavage assays with 3Cpro or 2Apro of HeLa S10
lysates in the presence or absence of eRF3 or Paip2 were analyzed by immu-
noblot with polyclonal anti-G3BP1 or anti-eIF4GI antibodies.
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His-eIF4B, MBP-unr, GST, GST-Tob, GST-4G or GST-Paip1)
no effect on the cleavage of PABP was observed with either
3Cpro or 2Apro (data not shown). Thus, eRF3 and Paip2 were
found to inhibit cleavage of both recombinant and endogenous
PABP, and several other PABP-binding proteins had no effect in
either context.
Previously we have shown that cytoplasmic PABP that did
not sediment with ribosomes (S200 fractions) was relatively
resistant to cleavage with 3Cpro, whereas the fraction of PABP
that did sediment with ribosomes (P200) or salt-washed
ribosomes (SWRibo) was more susceptible to cleavage. The
basis for the cleavage-resistance in certain fractions may be due
to the presence of endogenous Paip2 in these samples. We
examined the distribution of PABP and Paip2 on sucrose
gradients and found nearly all Paip2 to sediment slowly in
gradients and not stably associated with 80S ribosomes or
polysomes (Fig. 7B). This was consistent with Paip2 being
present in S200 fractions and partly inhibiting cleavage. Similar
analysis of eRF3 sedimentation was not performed due to
unavailability of antisera. In direct assays, 3Cpro cleaved PABP
in S200 fractions relatively poorly, however, addition of exo-genous Paip2 only slightly inhibited this cleavage (Fig. 6A,
lanes 8 and 9). In contrast, 2Apro cleaved PABP in S200 frac-
tions more efficiently and this cleavage was effectively in-
hibited by Paip2 addition (Fig. 6B, lanes 5 and 6). This suggests
that Paip2 may interact with a portion of the PABP susceptible
to 2Apro in this fraction, but not PABP in other conformations or
complexes that can be cleaved with 3Cpro. It also suggests that
within the S200 fraction, a portion of PABP exists in two
exclusive conformations or complexes, one that allows access
to the 2Apro site and Paip2 but largely blocks access by 3Cpro,
and vice versa.
In contrast to the partial cleavage-resistance of PABP in S200
fractions, ribosome-associated PABP is much more susceptible
to cleavage. While only 40–75% of PABP in S10 lysates is
cleaved in vitro by 3Cpro, the crude ribosome pellet fraction
(SWRibo, Fig. 6A, lanes 5 and 6), which is deficient in endo-
genous Paip2, is cleaved by 95%. As reported previously, this
fraction is very resistant to 2Apro cleavage (Fig. 6B, lanes 2
and 3). When we examined ribosome fractions taken from PV-
infected cells at 4 h p.i. we found the same high cleavage
susceptibility to 3Cpro as observed in uninfected cells (Fig. 6C,
lanes 5 and 8). At 4 h p.i. 90% of translating ribosomes are
associated with viral mRNA since host translation has been
largely shutoff. Interestingly, the SWRibo fraction (which is
stripped of most initiation factors) from infected cells contained
no PABP cleavage products (Fig. 6C, lane 7). Nonetheless, the
intact PABP associated with viral mRNA or cellular mRNAwas
equally and highly susceptible to 3Cpro cleavage (compare
subpanels A and C of Fig. 6). One difference found was that
cleavage site selection was altered; ribosome-associated
PABP in uninfected cells was cleaved to produce both 3Ccp
and 3CAltcp, whereas in mid-PV infection, there was a strong
selection of 3CAltcp. This was not the case with crude ribosome/
initiation factor fractions (PV-200) in which both cleavage sites
were used (Fig. 6C, lanes 5 and 6). In agreement with these
results, we found that polysome gradient fractions from mock-
infected cells, or cells infected with PV at 4 or 7 h p.i., were all
equally susceptible to cleavage by 3Cpro (data not shown), again
suggesting that PABP within cellular or viral polysomes is
equally susceptible to 3Cpro cleavage. Paip2 was found to inhibit
cleavage of uninfected and viral ribosome-associated PABPs
equally, however, the inhibition of cleavage was incomplete
(~50%) in each case.
Paip2 inhibition of 2A-mediated cleavage of non-ribosome
associated PABP
Since Paip2 was found to inhibit PABP cleavage in crude
ribosome fractions,wewanted to test potential inhibition of PABP
cleavage within 40S, 80S or polyribosome fractions enriched by
sucrose gradient sedimentation. Cleavage of PABP in polysomes
has not been examined before. PABP sedimented with non-
ribosome fractions, 40S and 80S ribosomes and polysome
fractions (Fig. 7B). Addition of 3Cpro to each of these fractions
led to partial cleavage in every case, and only slightly higher
percent cleavage of PABP in polysome fractions (fraction 6–8) or
40S–80S fractions (fractions 4–5) were observed compared to
Fig. 6. Paip2 inhibits cleavage of cleavage-susceptible or cleavage-resistant PABP fractions. A. 3Cpro was incubated with HeLa S10 lysate, salt-washed ribosomes
(SWRibo) or non-polysome fractions containing PABP (S200). Some reactions contained 3Cpro and GST-Paip2 (500 ng) as indicated or were incubated with buffer
(mock). B. HeLa fractions were incubated with buffer (mock), with 2Apro alone or 2Apro plus GST-Paip2. C. Similar HeLa cell fractions prepared from PV-infected
cells at 4 h post-infection were incubated with 3C and/or GST-Paip2 as indicated. PV-P200 indicates crude pelleted ribosome fraction before initiation factors are
stripped off with high salt. All fractions were analyzed for PABP cleavage by immunoblot and densitometry. The migration of the molecular weight markers is shown
on the left, and on the right, the location of full-length PABP (FL) and its cleavage products (cp) for the 2A- and 3C-proteinases.
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enhance cleavage have been lost by the sucrose sedimentation
procedure. When Paip2 was added to each cleavage reaction, a
partial and variable inhibition of PABP cleavage was observedFig. 7. Paip2 differentially enhances the stability of PABP associated with polysom
ribosome and polysome peaks with the collected fractions is indicated in the grap
(lower panel) in polysome gradient fractions. C. Sucrose gradient fractions (50 µl
(1 µg) (lower panel) and extent of cleavage determined by immunoblot analysis. D. S
GST-Paip2 (lower panel) and the extent of cleavage determined by immunoblot ana(Fig. 7C, compare panels). Production of 3Ccp from polysome
fractions was inhibited more strongly by Paip2. When 2Apro was
incubated with these sucrose fractions, only PABP in slow-
sedimenting, non-ribosome-associated fractions (1–3) wases. A. HeLa polysome gradient fractions analyzed by UV trace. Location of
h. B. Immunoblot analysis of the distribution of PABP (top panel) or Paip2
) were incubated with 3Cpro (1.5 µg) (upper panel) or 3Cpro plus GST-Paip2
ucrose gradient fractions were incubated with 2Apro (upper panel) or 2Apro plus
lysis.
Fig. 8. Viral polysomes contain exclusively intact PABP. A. Autoradiograph showing 35S-met/cys pulse-label analysis of host and viral translation in mock-infected or
PV-infected HeLa cells. B. Analysis of PABP cleavage in polysomes in mock- (top panel) or PV-infected cells at 4 h p.i. (middle panel) or 7 h p.i. (bottom panel). UV
absorbance profiles are depicted in panels on the left. Immunoblots show the presence of PABP or its 2A- or 3C-cleavage products (cp) (right panels).
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(Fig. 7D). In contrast to 3Cpro cleavage, the 2Apro cleavage
in these fractions was strongly inhibited by Paip2 (Fig. 7D), in
agreement with S200 cleavage data (Fig. 6B). This is interest-
ing since these fractions already contain endogenous Paip2. We
endeavored to estimate endogenous Paip2 and PABP concentra-
tions via immunoblot analysis of serial dilutions of fractions and
recombinant Paip2 or PABP (data not shown). We estimate that
PABP is present at a large molar excess in comparison to Paip2
(4 µM PABP versus 20 nM Paip2 in S10 lysate), even in fractions
1–3 of the gradient, thus providing an explanation for partial
2Apro cleavage of PABP in these fractions.
PABP associated with viral polysomes is cleaved late during
poliovirus infection
Since crude viral ribosome fractions contained no detectable
PABP cleavage products, and yet were equally susceptible
to 3Cpro cleavage as uninfected ribosome fractions in vitro
(Fig. 6), we wondered if there was any temporal discrimination
of cleavage of PABP associated with viral polysomes that may
allow continued viral translation after host translation was
shutoff. 35S-methionine pulse-label analysis on PV-infected
HeLa cells showed that as expected, a strong host translational
shutoff was induced by the viral infection leading to the almost
exclusive production of viral proteins by 4–5 h p.i. (Fig. 8A).
Viral translation sharply declined by 7 h p.i. As seen before,
PABP from mock-infected cells was distributed throughout the
entire polysome gradient (Fig. 8B, top panel). By 4 h p.i., during
the phase of viral infection when host translation is shutoff
(host polysomes are disassembled) and viral polysomes become
predominant, there was a large, but incomplete loss of PABP inthe polysome region (Fig. 8, middle panel, fractions 6,8) and a
shift toward non-ribosome associated (fraction 1) and 40–80S
ribosome fractions (fractions 3,5). PABP cleavage products
mostly remained associated with 40–80S ribosome fractions
and did not release into the slowest sedimenting non-ribosome
associated fractions. Interestingly, PABP cleavage products
were not associated with active viral polysomes, suggest-
ing intact PABP is required for viral translation (Kuyumcu-
Martinez et al., 2004b). Interestingly, by 7 h p.i. when viral
translation was steeply declining there was still intact PABP
associated with polysomes, however, PABP cleavage pro-
ducts now remained associated with viral polysome fractions
(Fig. 8B, bottom panel, fractions 6,8). These PABP cps may
contribute to inhibition of viral translation.
3CD and 3Cpro cleave PABP with equal efficiency
3CD is the precursor of mature 3Cpro and is present in
infected cells at much higher concentrations than fully processed
3Cpro. 3CD has no polymerase activity but serves as an active
proteinase with cleavage specificity that overlaps, but is dis-
tinct from 3Cpro, especially in its ability to cleave PV capsid
precursors with much higher efficiency (Harris et al., 1992; Jore
et al., 1988; Parsley et al., 1999; Ypma-Wong et al., 1988). 3CD
has not been tested versus PABP substrates in cleavage assays,
thus the relevant viral proteinase that cleaves PABP in cells
remains undetermined. Active 3CD (containing mutations at the
3Cpro–3Dpol junction that inhibit processing to 3Cpro and 3Dpol)
and 3Cpro were standardized to equal proteinase units using
radiolabeled polypeptide substrate containing the P2–P3 junc-
tion of the viral polyprotein as reported previously (Fig. 9A)
(Parsley et al., 1999). The recombinant 3CD was shown to have
Fig. 9. Poliovirus 3CD proteinase cleaves PABP. A. Standardization of 3Cpro and 3CD proteinase activity based on the ability of each proteinase to cleave at the P2–P3
junction of the viral polyprotein (previously shown to have equal proteinase susceptibility against 3Cpro and 3CD proteinases (Parsley et al., 1999)). One proteinase
unit was defined as the amount of proteinase required to cleave 50% of the 2C′3AB substrate in 30 min at 30 °C. B. HeLa S10 lysates (100 µg), SWRibo fraction
(100 µg), or recombinant His-PABP (200 ng) was incubated with 1 or 3 proteinase units of either 3Cpro or 3CD proteinase. Equivalent proteinase units of 3Cpro and
3CD contained approximately 1.2-fold molar excess of 3CD over 3Cpro. Cleavage was performed at 37 °C for 1 h, followed by immunoblot analysis.
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viral polyprotein, whereas equimolar amounts of 3C proteinase
failed to cleave the P1 peptide, as reported previously (Parsley
et al., 1999) (data not shown). When equivalent proteinase units
of 3CD and 3Cpro were used to cleave endogenous PABP in
HeLa S10 lysates, SWRibo fractions, as well as recombinant
His-PABP substrates, we found that both proteinases cleaved
all PABP substrates with near equivalent efficiency (Fig. 9B).
Another recombinant HA-tagged PABP was also equally effi-
ciently cleaved by both proteinases (data not shown). This
suggested that in the context of a viral infection, more PABP
processing may be catalyzed by 3CD rather than 3Cpro, due to
large molar excess of the former.
We examined PABP cleavage in the context of viral RNA
sequences and PCBP2 in order to determine if formation of an
RNP complex containing PCBP2 and PABP bound to the 5′ andFig. 10. Cleavage of PABP in mRNP complexes. Purified PABP and PCBP2 were inc
A71 bracketing a FLuc open reading frame. RNA, PABP and PCBP2 were used in a
alone or PABP plus PCBP2 were incubated with 3Cpro, 3CD or a combination of 3Cpro
when combined, the amount of each was halved in reactions. Reactions were incubate
indicated, the asterisk indicates a cross reactive protein. Calculated percent cleavage3′ regions of a viral minigenome RNAwould activate a higher
degree of PABP cleavage. The relative cleavage activity of
3Cpro and 3CD was also measured separately and together with
RNA and PCBP2 in this context. 3Cpro and 3CD were used at
equivalent protein concentration (0.1 µg/µl), resulting in higher
cleavage with 3Cpro than 3CD in these assays due to higher
molar concentration (Fig. 10). When viral minigenome RNA
containing a poly(A) segment was added, the PABP was clea-
ved more efficiently by 3Cpro (76% to 88%), as has been
described before (Kuyumcu-Martinez et al., 2002), but PABP
cleavage by 3CD did not change (31% versus 32%). Addition of
PCBP2 alone caused a slight decrease in PABP cleavage by
both proteinases which also mitigated the RNA enhancement
of 3Cpro cleavage activity. With either protease, addition of
RNA plus PCBP2 did not activate higher levels of PABP
cleavage than with PABP alone. When both 3Cpro and 3CDubated with minigenome viral RNA containing a complete 5′ UTR and 3′ UTR-
1:3:8 molar ratio (0.24 µg, 0.15 µg, 0.2 µg). Combinations of mRNPs, or PABP
and 3CD. 3Cpro (0.1 µg) and 3CD (0.15 µg) were used at a molar ratio of 2:1 and
d for 3 h and examined by immunoblot and densitometry. PABP and PABPcp are
is shown below each lane.
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total protease) no further increase in PABP cleavage was
observed, suggesting that any potential 3Cpro–3CD complexes
did not have increased cleavage activity versus this substrate.
When the proteases were used in combination, the addition of
RNA did not increase PABP cleavage, nor did PCBP2. We
verified that PCBP2 and PABP interacted with the minogenome
RNA by performing electrophoretic mobility assays and
observed a supershift when both proteins were used together
(data not shown). Taken together, since 3Cpro cleavage activity,
but not 3CD cleavage activity was enhanced by viral poly(A)
RNA, this suggests that 3Cpro may be the more active protease
versus PABP in cells.
Discussion
One of the hallmarks of enterovirus infection is the inhibition
of host cell protein synthesis through cleavage of eIF4G and
PABP. A growing number of viruses are now known to cleave
PABP during infection, including caliciviruses, hepatitis Avirus
and HIV, thus its evolutionary importance in virus replication is
growing (Alvarez et al., 2006; Kuyumcu-Martinez et al., 2004a;
Zhang et al., 2007). While eIF4G is efficiently cleaved to
completion early during PV infection, only a third of cyto-
plasmic PABP is cleaved at this time, and only 50–60% by late
infection. Though partial PABP cleavage during viral infection
may result from its huge abundance in cells, elucidation of the
precise and restricted PABP–RNP complex(es) that is prefer-
entially targeted by viral proteases is important to determine.
We have shown that PABP is cleaved with biphasic kinetics by
both viral proteinases, revealing a cleavage-resistant PABP
population and we have shown that two PABP-binding pro-
teins, eRF3 and Paip2, block PABP cleavage by two different
proteinases.
Our results indicate that purified PABP inherently adopts
conformations that are proteinase-resistant. Because the PABP
3Cpro cleavage sites do not perfectly match the 3Cpro consensus
cleavage site, incomplete PABP cleavage in cells could have
resulted from reduced binding and catalytic rates. The results in
Fig. 1 show that 3Cpro can easily cleave PABP with fast initial
cleavage kinetics, indicating that 3Cpro was amply active and
that the non-consensus cleavage site sequence only minimally
impedes cleavage. However, the abrupt reduction in PABP
cleavage rate after 10–30 min suggests that at least two PABP
pools exist in the population, one highly susceptible to cleavage
and another configuration(s) that is refractory to cleavage. Slow
secondary rate of cleavage by 3Cpro suggests that interconver-
sion between PABP conformations is inefficient. PABP cleavage
by 2Apro showed slower initial cleavage rates than 3Cpro, but
extended incubation time also revealed a biphasic cleavage
profile. In these reactions, PABP likely interacts with itself
through a well known, but poorly characterized oligomerization
property (Kuhn and Pieler, 1996). We have examined our PABP
preparations by gel filtration and found anomalous migration
(data not shown). Additionally, a recent report shows yeast
PABPmigrates in native gels as clear oligomers. This report also
suggested that cysteine residues (conserved in human PABP)within the N-terminal RNA-binding component of yeast PABP
allow for a circular conformation to form in some PABP mo-
lecules through the formation of a disulfide bond. (Yao et al.,
2007). Such a configuration may block cleavage with 2Apro,
which cleaved more readily with high DTT concentration
(Fig. 2), however 3Cpro cleavage was not influenced by this
parameter. This suggests that 2Apro and 3Cpro may recognize
two different PABP pools. Importantly, biphasic PABP cleavage
kinetics was also observed in HeLa extracts as well, however
cleavage was consistently more efficient than with purified
PABP. This suggests that factors present in lysates (e.g. poly(A)
RNA) enhance PABP cleavage.
We previously reported that 3Cpro primarily targets PABP
molecules associated with the translational machinery, but mo-
lecular details were undetermined. Here we show that cleavage
of PABP by viral proteinases is inhibited by Paip2 and eRF3,
both of which function as translational repressors, but not by
other the PABP-associated factors Tob1, Paip1, eIF4B, eIF4G,
PCBP2 or unr (Fig. 3 and data not shown). eRF3 is proposed to
transiently interact with polysome-bound PABP when ribo-
somes pause at stop codons, thus, eRF3 may only exert a minor
inhibitory effect on overall PABP cleavage in a cell. However,
other unknown interactions of eRF3 and PABP away from the
context of translating polysomes remain possible. Paip2 is a
general inhibitor of PABP function that can strip PABP off poly
(A) RNA. This interaction is relatively stable and could interfere
with PABP cleavage by steric effects and by reducing pools of
poly(A)-bound PABP, which is more susceptible to 3Cpro than
free PABP (Khaleghpour et al., 2001b; Kuyumcu-Martinez
et al., 2002). A new Paip2 homolog, termed Paip2B, has similar
functions in regulating PABP and releasing it from poly(A) RNA
(Berlanga et al., 2006), thus it is likely that Paip2B can also
inhibit the cleavage of PABP by viral proteinases.
Interestingly, Paip1 did not inhibit PABP cleavage, despite
the fact it binds PABP at two sites that partly overlap the Paip2
binding sites. This difference could be attributed to the fact that
the binding of Paip1 to PABP occurs with a 1:1 stoichiometry
and with an apparent Kd of 1.9 nM, whereas Paip2 binds PABP
with a 2:1 stoichiometry and Kd values of 0.66 and 74 nM
(Khaleghpour et al., 2001a). Indeed, structural and thermody-
namic studies of the binding of eRF3 and Paip1 or 2 peptides to
the PABC domain of PABP indicated that binding of Paip1
causes amore drastic conformational change than Paip2 (Kozlov
et al., 2004, 2001). Moreover, binding of Paip2 and eRF3
peptides (more than Paip1) is highly dependent on hydrophobic
interactions or involves a larger protein/peptide contact sur-
face (Kozlov et al., 2004). Since proteinases probe substrate
structure, the differential cleavage results obtained with Paip1
and Paip2 suggest that PABP associated with these proteins
adopts different conformations or that steric hindrance occurs
only with Paip2.
Despite the finding that Paip2 can inhibit PABP cleavage by
both proteinases and in all HeLa fractions tested, it probably
plays a lesser role in modulating overall PABP cleavage in cells.
Examination of actual protein concentrations in lysates indicated
that Paip2 exists at levels approximately 50-fold lower than
PABP, seemingly too low to account for the differential and
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fractions thereof. 2Apro only cleaved PABP within slowly
sedimenting complexes in polysome gradients, however, the
bulk of the cellular Paip2 was already present in these same
polysome gradient fractions, demonstrating that insufficient
endogenous Paip2 was present to block cleavage. Further, the
PABP in these fractions could interact with Paip2 since addition
of exogenous Paip2 strongly inhibited its cleavage with 2Apro
(Fig. 7).
We also found an interesting inverse relationship between
2Apro and 3Cpro cleavage of PABP in HeLa cell fractions where
PABP molecules within non-ribosome complexes (S200) were
cleaved more efficiently by 2Apro than by 3Cpro. Conversely,
PABP found within crude salt-washed ribosome extracts
(SWRibo) was efficiently cleaved by 3Cpro, but not 2Apro
(Fig. 6). This relationship partly extended to polysome fractions
where 2A only cleaved non-ribosome associated PABP. The
2Apro cleavage site on PABP lies between the two 3Cpro sites in
the linear sequence, yet no knowledge of true structure in this
region is available, and the cleavage sites may actually lie in
different surface regions. Our data show that each PV proteinase
targets one of at least two distinct PABP populations, which
present different conformational constraints. These unique
conformations are likely modulated by differing host factors
in complexes with PABP, which promote or inhibit cleavage of
one or the other proteinase.
Why would 2Apro evolve to target non-ribosome-associated
PABP but not 3Cpro? 3Cpro is the default picornavirus
proteinase that has evolutionary homologs in other virus
families such as norovirus, whereas 2Apro homologs are absent
in many other virus families. Thus 3Cpro may have evolved
early on to regulate viral and cellular translation and thus targets
PABP in active polysomes. One possible function of the pool of
PABP that is not associated with mRNA is to provide PABP for
nascent RNA transcripts. Cleavage of this PABP population by
2Apro, the accessory proteinase, may serve to prevent nascent
viral RNAs from acquiring intact PABP and being translated
later in infection, thus aiding the process leading to packag-
ing of vRNA. We have determined that PV virion RNA is
completely devoid of PABP (data not shown).
PABP cleavage inhibits not only cap-dependent transla-
tion, but also PV translation (Bonderoff et al., submitted for
publication) and HAV translation (Zhang et al., 2007). Since
viral translation persists for several hours longer than cellular
translation in cells, we also investigated if viral proteinases
preferentially target PABP cleavage on cellular versus viral
polysomes as part of a mechanism that promotes viral trans-
lation. Surprisingly, we determined that PABP on either type of
polysome pool was equally and highly susceptible to cleavage
with 3Cpro (Fig. 6). This suggests that viral polysomes do not
stably bind factors that inhibit PABP cleavage. However,
examination of PABP on active viral polysomes purified from
infected cells shows that exclusively intact PABP was present;
all PABP cleavage products migrated with 40–80S ribosome
subunits (Figs. 6 and 8). Thus, some form of PABP cleavage
discrimination may exist in cells to restrict PABP cleavage on
viral polysomes until after cleavage on cellular polysomesoccurs. Also, viral proteinases must retain a population of intact
PABP during the exponential phase of the viral growth cycle to
support translation of the expanding pool of nascent viral
RNAs. One hypothesis is that the non-poly(A) associated PABP
which is resistant to 3Cpro cleavage (S200 pool) may represent
this population of intact PABP for nascent viral mRNA. Further,
there was a temporal correlation between the downregulation
of viral translation during late PV infection and appearance
of PABP cps associating with viral polysomes (Fig. 8B). This
supports the hypothesis that intact PABP is required for viral
translation.
We also investigated if 3Cpro or 3CD is the major proteinase
that cleaves PABP. Since 3Cpro and 3CD had nearly equivalent
cleavage activity on purified PABP, yet 3CD is more abundant
in infected cells, 3CD may be dominant. However, RNA
stimulated 3Cpro cleavage of PABP but not 3CD cleavage of
PABP (Fig. 10), suggesting that 3Cpro is more effective versus
poly(A)-bound PABP, which is presumably the more important
target. These results make it unlikely that any preferential
cleavage of cellular versus viral polysome-bound PABP could
stem from regulation of 3CD processing into mature 3Cpro
during the course of infection. However, since we have shown
that 3CD is an active PABP-specific proteinase, and was not
inhibited by RNA, it likely plays a role in the cleavage of PABP
on viral mRNA.
3CD may play an important role in the switch from viral
translation to RNA replication, as it associates with the clo-
verleaf structure of the viral 5′ UTR and may mediate the
circularization of the viral genome by interacting with
PABP (Herold and Andino, 2001). Since PABP cleavage,
along with cleavage of PTB and PCBP2 (Back et al., 2002;
Perera et al., 2007) all regulate the end of viral translation,
3CD and PCBP2 coordinately binding the viral cloverleaf
and PABP may strongly stimulate PABP cleavage as well
as cleavage of PCBP2 or PTB. We tested this hypothesis in
vitro and did not observe a stimulation of cleavage activity
when complexes of 3CD, PCBP2, PABP and viral minige-
nome RNA could form. It would be interesting to examine if
addition of other viral replicase components 3AB, VPg-pUpU
or 2C to this system can stimulate PABP or even PCBP2
cleavage.
In summary, this study provides insights about the mechan-
isms that modulate PABP cleavage during PV infection. PABP
inherently exhibits a dual proteinase sensitive/resistant pheno-
type due to formation of multiple conformations, partly via self-
oligomerization. Further, several types of PABP/protein/mRNP
complexes influence these cleavage reactions but remain
undefined at a molecular level. Interactions of PABP with
eRF3 and Paip2 inhibit cleavage reactions with both viral
proteinases, however, they likely play a minor role in regulation
of PABP cleavage during virus infection. More work remains to
determine the primary PABP substrate complexes that 3Cpro
and 3CD have evolved to cleave most efficiently. Such
complexes may exist only in a transient conformation that
PABP adopts at a particular stage of the translation initiation,
elongation or termination phases, or at a particular PABPmoiety
bound to poly(A).
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Cells and virus
HeLa S3 cells were grown in suspension in defined SMEM-
Joklik media supplemented with 9% bovine calf serum, 1% fetal
bovine serum and penicillin/streptomycin (Invitrogen). Polio-
virus type 1 (Mahoney) was grown and purified as previously
described (Brown and Ehrenfeld, 1979). HeLa S3 cells were
infected with poliovirus at a multiplicity of infection of 10 pfu/
cell. Serum was added to the cells 30 min after infection to a
final concentration of 3%. Aliquots of cells were taken at dif-
ferent time points throughout the infection and subjected to
fractionation or used to examine translation levels during in-
fection. Translational shutoff during viral infection was assessed
by pulse labeling 1×106 cells at different time points for 30 min,
for which the cells were resuspended in 100 µl of (-Met/-Cys)
DMEM, supplemented with 30 µCi of 35S-methionine. After the
30-minute pulse, the cells were harvested and lysed in CHAPS
buffer on ice for 30 min. The supernatant containing the soluble
proteins was then loaded onto a 12% SDS-PAGE gel and ana-
lyzed by autoradiography.
Plasmids
The PABP expression plasmids pET28a-His-PABP have
been described elsewhere (Kuyumcu-Martinez et al., 2004b).
The plasmid pET-His-PCBP2 was constructed by insertion of
the PCBP2 coding sequence from pQE30-PCBP2 (Blyn et al.,
1996) into pET28a(+). Plasmids encoding GST-Paip1 and GST-
Paip2 (pGEX6P-Paip1/2) were a kind gift from Dr. Nahum
Sonenberg. The plasmid pET-His-4B, encoding human eIF4B
was obtained from Dr. Nadia Korneeva. The plasmid pheRF3,
encoding human eRF3 was a kind gift of Dr. Bertrand Cosson.
The pMBP-unr construct was a gift from Dr. Ann-Bin Shyu.
The plasmid pGEX5X-1-TobN (1–170) was a kind gift from
Dr. Tadashi Yamamoto. The construct pGST-4G (41–220) was
made by PCR-amplification of the PABP-binding motif from
pSPORT-4GI and the PCR product corresponding to residues
41–220 of eIF4G flanked by XhoI sites was then inserted into
the XhoI site of pGEX-4T2. The resulting construct, GST-4G
(41–220) was confirmed by sequencing and the GST-4G
peptide expressed in DH5α cells and purified according to the
manufacturer's protocols.
Production of recombinant proteins
Purified coxsackievirus B3 (CVB3) 2A- and PV 3C-pro-
teinases were expressed and purified as described previously
(Joachims et al., 1999; Liebig et al., 1993). Active 3CD bearing
a Ser insertion mutation near the 3C–3D junction to block
autocleavage was expressed and purified as previously des-
cribed (Parsley et al., 1999). Recombinant His-PABP was ex-
pressed from the plasmid pET28-His-PABP and purified by
metal affinity chromatography as described elsewhere
(Kuyumcu-Martinez et al., 2004b). Recombinant His-eIF4B,
His-PCBP2 and His-eRF3 were expressed and purified usingthe same protocol as for the His-PABP. The MBP-unr protein
was expressed and purified according to published protocols
(Chang et al., 2004). GST-Paip1 and GST-Paip2 were expressed
and purified from bacteria as previously described (Khalegh-
pour et al., 2001a; Roy et al., 2002). GST and GST-Tob 1–170
were purified similarly to the GST-Paip proteins. Following
purification, all proteins were dialyzed in standard dialysis
buffer containing 100 mM NaCl, 25 mM Tris (pH 8.0) and 10%
glycerol.
Proteinase activity standardization
The plasmid pTM1-2C3AB, kindly provided by Dr. Bert
Semler, was linearized with XhoI and used for in vitro tran-
scription with T7 polymerase. The resulting RNAwas used for in
vitro translation in rabbit reticulocyte lysate (Promega),
generating a 52 kDa polypeptide comprised of the 2C and the
3AB polypeptides of the viral polyprotein. Serial dilutions of
equimolar concentrations of the purified 3C and 3CD protei-
nases were used to cleave the radiolabeled substrate for 30min at
30 °C. One proteinase unit was defined as the amount of
proteinase required for cleavage of 50% of the substrate in this
assay.
In vitro cleavage assays
Purified PABP-HA, His-PABP or HeLa cell lysates were
incubated with the corresponding amount of proteinase and
exogenous protein or standard dialysis buffer control at 37 °C
for 1 h, or for extended times as indicated. Typical cleavage
reaction conditions contained 20 mM Hepes (pH 7.4), 150 mM
KOAc and 1 mMDTTor 3 mMDTTas indicated. Proteins were
then resolved on a 9% SDS-PAGE gel and analyzed by Western
Blot with an anti-PABP rabbit polyclonal antibody using
enhanced chemiluminescence reagents (Pierce).
HeLa cell fractionation
Mock- or PV-infected HeLa cells were harvested at different
times during infection and fractionated into further compart-
ments. The cell pellet was washed with PBS plus cycloheximide
(160 µg/ml). The cell pellet was then resuspended in two
volumes of passive lysis buffer (10 mM potassium chloride
(KCl), 2.5 mM dithiothreitol, 1.2 mM magnesium acetate and
25 mM Hepes, pH 7.4), incubated on ice for 10 min, then lysed
with 25 strokes in a Dounce homogenizer. The total lysate was
clarified by centrifugation at 4 °C at 10,000 ×g for 15 min to
obtain the total cytoplasmic extract (S10 lysate). Further
fractionation into S200/P200, RSW and SWRibo fractions
was performed as described before (Kuyumcu-Martinez et al.,
2002).
Polysome gradients
The HeLa S10 cell lysates were supplemented with cyc-
loheximide and layered on top of 10–50% sucrose gradients
containing 10 mM Tris (pH 7.2), 140 mM sodium chloride and
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ultracentrifugation in a SW41 rotor for 3 h at 35,000 RPM at
4 °C. The gradients were collected with continuous monitoring
at 260 nm using an ISCO UA-6 UV detector and Retriever 500
fraction collector. Each fraction was then analyzed by
immunoblot for the presence of PABP or Paip2 protein.
Immunoblot analysis
Western Blot analysis was conducted using rabbit polyclonal
antisera raised against the synthetic peptide (GIDDERLR-
KEFSPFGT) within the RRM4 of PABP as shown before
(Kuyumcu-Martinez et al., 2004a). Rabbit polyclonal antisera
against eIF4GI and G3BP1 have been described elsewhere (Byrd
et al., 2005; White et al., 2007). Anti-Paip2 immunoblots were
performed using a rabbit polyclonal antibody against Paip 2, kindly
supplied by Dr. Nahum Sonenberg. Densitometric analysis of
protein cleavage in immunoblots was determined using ImageJ
software. Percent cleavage was computed from densitometry data
as the combined average of percent decline in PABP signal and the
ratio of cleavage product/(cleavage product+PABP) in each lane.
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